In a research report released Friday, Canaccord Genuity analyst Adam Walsh initiated coverage on shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) with a Buy rating and …
It’s been an eventful week on the pipeline front with companies like Biogen Inc (NASDAQ:BIIB), Prothena Corporation PLC (NASDAQ:PRTA) and Vertex Pharmaceuticals Incorporated …
In a research report published Monday, Maxim Group analyst Jason Kolbert reiterated a Buy rating on Vertex Pharmaceuticals (NASDAQ:VRTX) and raised his price …
In a research report released today, H.C.
Maxim Group analyst Jason Kolbert reiterated a Buy rating on Vertex Pharmaceuticals (NASDAQ:VRTX) and raised his share price target to $122 (from $117), …
In a research report issued to investors Wednesday, Oppenheimer analyst Yigal Nochomovitz reiterated a Perform rating on Vertex Pharmaceuticals (NASDAQ:VRTX), following the company’s third-quarter …
In a research report issued today, H.C.
In a report sent to investors today, Oppenheimer analyst Yigal Nochomovitz maintained a Perform rating on Vertex Pharmaceuticals (NASDAQ:VRTX), following the positive FDA advisory panel …
In a research report issued today, Oppenheimer analyst Yigal Nochomovitz maintained a Perform rating on Vertex Pharmaceuticals (NASDAQ:VRTX), while no price target was provided. Nochomovitz …
